• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

5-(3,3-二甲基-1-三氮烯基)咪唑-4-甲酰胺及其代谢产物对诺维科夫肝癌细胞的影响。

Effects of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide and its metabolites on Novikoff hepatoma cells.

作者信息

Beal D D, Skibba J L, Whitnable K K, Bryan G T

出版信息

Cancer Res. 1976 Aug;36(8):2827-31.

PMID:179708
Abstract

Studies were undertaken to determine the effects of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (DTIC) and its metabolites on the growth and macromolecular synthesis of Novikoff hepatoma cells in culture. DTIC (3.0 mM) in light decreased the viable cell count by 90% within 96 hr. DTIC protected from light, 2-azahypoxanthine, dimethylamine, and 5-aminoimidazole-4-carboxamide, all at 3.0 mM, reduced the rate of cellular proliferation. 5-Diazoimidazole-4-carboxamide (1.0 mM) and 5-(3-methyl-1-triazeno)imidazole-4-carboxamide (3.0 mM) decreased the viable cell count by 99%. Effects on macromolecular synthesis were determined by the rate of incorporation of the appropriate 3H-labeled precursor. Results after 6 hr are given as percentage of controls. DTIC (1.0 mM) in light inhibited DNA (8%), RNA (41%), and protein (63%) synthesis. DTIC (1.0 mM) protected from light inhibited DNA (12%) and RNA (57%) synthesis. 5-Diazoimidazole-4-carboxamide (0.1 mM) inhibited DNA (1%), RNA (9%), and protein (1%) synthesis. 5-(3-Methyl-1-triazeno)imidazole-4-carboxamide (1.0 mM) inhibited DNA (72%) and protein (65%) synthesis but stimulated RNA (127%) synthesis. 2-Azahypoxanthine (1.0 mM) inhibited DNA (43%), RNA 82%) and protein (28%) synthesis. 5-Aminoimidazole-4-carboxamide (3.0 mM) stimulated DNA (354%) and RNA (266%) synthesis. These data show that DTIC is able to generate several toxic metabolites that may be responsible for its biological effects.

摘要

开展了多项研究以确定5 -(3,3 - 二甲基 - 1 - 三氮烯基)咪唑 - 4 - 甲酰胺(DTIC)及其代谢产物对培养的诺维科夫肝癌细胞生长和大分子合成的影响。光照条件下的DTIC(3.0 mM)在96小时内使活细胞数量减少了90%。避光条件下的DTIC、2 - 氮杂次黄嘌呤、二甲胺和5 - 氨基咪唑 - 4 - 甲酰胺,浓度均为3.0 mM,降低了细胞增殖速率。5 - 重氮咪唑 - 4 - 甲酰胺(1.0 mM)和5 -(3 - 甲基 - 1 - 三氮烯基)咪唑 - 4 - 甲酰胺(3.0 mM)使活细胞数量减少了99%。通过合适的3H标记前体的掺入速率来确定对大分子合成的影响。6小时后的结果以对照的百分比给出。光照条件下的DTIC(1.0 mM)抑制DNA(8%)、RNA(41%)和蛋白质(63%)合成。避光条件下的DTIC(1.0 mM)抑制DNA(12%)和RNA(57%)合成。5 - 重氮咪唑 - 4 - 甲酰胺(0.1 mM)抑制DNA(1%)、RNA(9%)和蛋白质(1%)合成。5 -(3 - 甲基 - 1 - 三氮烯基)咪唑 - 4 - 甲酰胺(1.0 mM)抑制DNA(72%)和蛋白质(65%)合成,但刺激RNA(127%)合成。2 - 氮杂次黄嘌呤(1.0 mM)抑制DNA(43%)、RNA(82%)和蛋白质(28%)合成。5 - 氨基咪唑 - 4 - 甲酰胺(3.0 mM)刺激DNA(354%)和RNA(266%)合成。这些数据表明DTIC能够产生几种可能对其生物学效应负责的有毒代谢产物。

相似文献

1
Effects of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide and its metabolites on Novikoff hepatoma cells.5-(3,3-二甲基-1-三氮烯基)咪唑-4-甲酰胺及其代谢产物对诺维科夫肝癌细胞的影响。
Cancer Res. 1976 Aug;36(8):2827-31.
2
Carcinogenicity of the antineoplastic agent, 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide, and its metabolites in rats.抗肿瘤药物5-(3,3-二甲基-1-三氮烯基)-咪唑-4-甲酰胺及其代谢产物对大鼠的致癌性。
J Natl Cancer Inst. 1975 Apr;54(4):951-7.
3
The effects of treatments with 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide in darkness and in light on survival and progression in Chinese hamster ovary cells in vitro.5-(3,3-二甲基-1-三氮烯基)咪唑-4-甲酰胺在黑暗和光照条件下处理对体外培养的中国仓鼠卵巢细胞存活和进展的影响
Cancer Res. 1974 Aug;34(8):1921-5.
4
Studies on the mechanism of action of DTIC (NSC-45388).氮烯咪胺(NSC - 45388)作用机制的研究。
Cancer Treat Rep. 1976 Feb;60(2):141-8.
5
Cellular and biochemical aspects of growth retardation in rat fetuses induced by maternal administration of selected anticancer agents.母体给予特定抗癌药物所致大鼠胎儿生长迟缓的细胞和生化方面
Teratology. 1975 Dec;12(3):259-70. doi: 10.1002/tera.1420120307.
6
Mechanism of action of inosine dialdehyde (NSC 118994) in the inhibition of proliferation of tumor cells in culture.肌苷二醛(NSC 118994)抑制培养中肿瘤细胞增殖的作用机制。
Cancer Res. 1977 Jul;37(7 Pt 1):2188-95.
7
Mechanism of action and pharmacology studies with DTIC (NSC-45388).达卡巴嗪(NSC-45388)的作用机制及药理学研究
Cancer Treat Rep. 1976 Feb;60(2):149-52.
8
Mechanisms of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (Dacarbazine) cytotoxicity toward Chinese hamster ovary cells in vitro are dictated by incubation conditions.5-(3,3-二甲基-1-三氮烯基)咪唑-4-甲酰胺(达卡巴嗪)对中国仓鼠卵巢细胞的体外细胞毒性机制取决于孵育条件。
Chem Biol Interact. 1986 Jun;58(3):319-31. doi: 10.1016/s0009-2797(86)80106-5.
9
5-(3-Hydroxymethyl-3-methyl-1-triazeno imidazole-4-carboxamide is a metabolite of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (DIC, DTIC NSC-45388).5-(3-羟甲基-3-甲基-1-三氮烯基)咪唑-4-甲酰胺是5-(3,3-二甲基-1-三氮烯基)咪唑-4-甲酰胺(DIC,DTIC NSC-45388)的一种代谢产物。
Cancer Lett. 1980 Sep;10(3):235-41. doi: 10.1016/0304-3835(80)90076-2.
10
Effect of inhibiting DNA, RNA, and protein synthesis of tumor cells on their susceptibility to killing by antibody and complement.抑制肿瘤细胞的DNA、RNA和蛋白质合成对其被抗体和补体杀伤敏感性的影响。
Cancer Res. 1977 May;37(5):1432-7.

引用本文的文献

1
Combined Therapy with Dacarbazine and Hyperthermia Induces Cytotoxicity in A375 and MNT-1 Melanoma Cells.达卡巴嗪联合热疗诱导 A375 和 MNT-1 黑色素瘤细胞细胞毒性。
Int J Mol Sci. 2022 Mar 25;23(7):3586. doi: 10.3390/ijms23073586.
2
Temozolomide and Other Alkylating Agents in Glioblastoma Therapy.替莫唑胺及其他烷化剂在胶质母细胞瘤治疗中的应用
Biomedicines. 2019 Sep 9;7(3):69. doi: 10.3390/biomedicines7030069.
3
Pharmacokinetics of dacarbazine (DTIC) in pregnancy.妊娠期间达卡巴嗪(DTIC)的药代动力学。
Cancer Chemother Pharmacol. 2018 Mar;81(3):455-460. doi: 10.1007/s00280-017-3511-6. Epub 2018 Jan 5.
4
Pharmacologic studies of anticancer drugs with the human tumor stem cell assay.采用人肿瘤干细胞检测法对抗癌药物进行的药理学研究。
Cancer Chemother Pharmacol. 1981;6(3):253-64. doi: 10.1007/BF00256978.
5
DTIC and CPZ cytotoxicities on established human melanocyte cell lines.达卡巴嗪(DTIC)和氯丙嗪(CPZ)对已建立的人黑素细胞系的细胞毒性。
Med Oncol Tumor Pharmacother. 1984;1(3):195-9. doi: 10.1007/BF02934141.
6
Clinical pharmacokinetics of high-dose DTIC.大剂量达卡巴嗪的临床药代动力学
Cancer Chemother Pharmacol. 1991;28(6):475-9. doi: 10.1007/BF00685826.
7
The antitumour agent 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide (DTIC) inhibits rat liver cAMP phosphodiesterase and amplifies hormone effects in hepatocytes and hepatoma cells.抗肿瘤药物5-(3,3-二甲基-1-三氮烯基)咪唑-4-甲酰胺(DTIC)可抑制大鼠肝脏中的环磷酸腺苷磷酸二酯酶,并增强激素对肝细胞和肝癌细胞的作用。
Br J Cancer. 1979 Nov;40(5):768-73. doi: 10.1038/bjc.1979.259.